Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994  and it became an official association (under Dutch law) in 2004.
Pharmaceutical Care is the pharmacist's contribution to the care of individuals, in order to optimize medicines use and improve health outcomes.

Conferences Working groups

Working group Guidelines and Indicators now official

During the 2020 PCNE General Assembly, the working group on Guidelines and Indicators was officially established. Although this working group has been active for some time already, it still needed apoproval according to the PCNE Regulations.

The leaders of this working group are Martina Teichert (the Netherlands) and Kenji Fujita (Australia). The working group can be contacted through the PCNE secretariat.

Below is the text of the official application of the Working Group.


 

 

PROPOSAL FOR THE OFFICIAL INSTALLATION OF A WORKING GROUP 'GUIDELINES AND INDICATORS' IN PCNE

Pharmaceutical care has become a core business of pharmacists in hospitals, ambulatory and community pharmacies in many countries. Guidelines are being developed to describe the care to be provided by pharmacists. The implementation of these guidelines should decrease undesired practice variation and stimulate research for more evidence regarding the recommendations. All these efforts will contribute to improve the quality of care, for patient populations as well as for individuals. The degree of guideline implementation can be measured by quality indicators.

Since 2016 PCNE has had workshops on the development of guidelines and indicators during our PCNE conferences. However, up to now a formal PCNE working group on guidelines and indicators has not formally been established yet. Herewith, Kenji Fujita and Martina Teichert propose the foundation of a formal PCNE Working Group on guidelines and indicators at the PCNE General Assembly in Egmond 2020.

To this we ask the board to propose this working group and to invite all PCNE members to join us as a member of the Working group. We intend to have at least one other PCNE member joining us in organizing the working group and elaborate on the working program (see below). We will, of course, invite all other interested PCNE members and workshop participants to participate in our work.
It is quite complex and time consuming to develop a guideline. Guideline recommendations are often accustomed to specific settings in the countries and healthcare systems, and their recognition is often also motivated by political considerations. Therefore we want to focus on quality indicators first.

Initial working plan

To make a start we want to focus on implementing recommendations from existing guidelines with the help of quality indicators. We want to focus on two parallel projects:
1. Develop a PCNE concept for quality indicators for pharmaceutical care: how to define them, what characteristics are important (‘syntax’), how to use them for what aims and with which stakeholders etc. This part would involve mainly scientists.

2. Develop a set of QIs for pharmaceutical care in diabetes that can be measured across different practices in different countries. To this – with a start of the working groups at Egmond 2020 – the most important guideline recommendations, pharmacy processes and patient outcomes to be achieved could be developed into an international measurable QI set. This project would involve community pharmacists with the aim to have about 10 community pharmacists within different countries to measure the set.

 

Detailed work plan for the coming 2 years on (1) PCNE definition of QIs and (2) a QI set with results on diabetes care

1. Timetable for the development of a PCNE definition for characteristics of quality indicators that provide meaningful information on the quality of pharmaceutical care.

 

Step

Action

Time

Who

Result

1.

Develop a common understanding on QIs – standardised syntax for QI indicators to be used across countries

 

 

 

a).

Develop a standardised syntax to be used

Feb 2020

Workshop Egmond

Standardised syntax

b)

systematic literature review and paraphrase work to Identify existing definitions of QIs, paraphrase the definitions using the standardised syntax developed in the workshop in order to ease comparison between definitions

March – June 2020

 

Core working group

Develop a survey

c)

Online survey with PCNE members To elicit opinions about issues discussed in the workshop

July - December 2020

PCNE members

 

d)

Develop a definition of QIs to be used by PCNE for pharmaceutical care indicators

February 2021

Working group

 

e)

Online survey with PCNE members to build consensus on the PCNE QI definition

March – Juni 2021

PCNE members

 

f)

Approval by the GA

February 2022

GA

Official PCNE QI definition

g)

Develop a paper

During process

Core group

 

 

2. Timetable to develop and measure a set of quality indicators for pharmaceutical care for diabetes patients.

 

Step

Action

Time

Who

Result

2.

Develop a set of QIs with scores measured on pharmaceutical care on diabetes in different countries

 

 

 

a).

To develop a first set to be used

Feb 2020

Workshop Egmond

First QI set for pharm care in diabetes to be used

b)

To finish a set of QI indicators by a systematic literature review on QIs used in pharm care for diabetes and paraphrase work

to define a QI set on diabetes

March – August 2020

 

Core working group

Develop a set and a survey

c)

To build consensus regarding the content validity of ‘QIs on diabetes: online Delphi survey with the working group for consensus on the QI set on diabetes – ideas how to measure the set within 20 pharmacies in different countries

September – October 2020

Working group

QI set on diabetes,

List of 20 pharmacies to measure the set

d)

To validate the measurement properties of QIs for diabetes by an online questionnaire in different countries (10 community pharmacies each)

January / February 2021

Core working group, pharmacies

Discuss first results during the PCNE symposium

e)

Evaluation of the scores

March – June 2021

Core working group

 

f)

To identify implementation issues ((e.g. unintended consequences, potential barriers and facilitators) by conducting interview (a focus group / in-depth interview)

July - October

Core working group

 

g)

Share the results and prepare a paper

November 2021 – February 2022

Core working group with participants

Submission of paper

 

Conclusion

The PCNE members Martina Teichert and Kenji Fujita ask the Board to propose the foundation of a new working group to the General Assembly ‘The PCNE working group on Guidelines and Indicators’. Hopefully together with one more PCNE member, they will take the lead.

The working group will first focus on (1) developing a PCNE concept for quality indicators for pharmaceutical care, and (2) the development of a set of QI indicators for pharmaceutical care in diabetes that can be measured across different practices in different countries. They will report annually on the progress of the work.

Den Haag/Sydney, 20 January 2020.